![](/img/cover-not-exists.png)
Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.05.002
Date:
July, 2019
File:
PDF, 351 KB
2019